Evaluation of elexacaftor–tezacaftor–ivacaftor treatment in individuals with cystic fibrosis and CFTRN1303K in the USA: a prospective, multicentre, open-label, single-arm trial
George M. Solomon, Rachel W. Linnemann, Rachel Rich, Ashleigh Streby, Brian Buehler, Eric Hunter, Kadambari Vijaykumar, William R Hunt, John J. Brewington, András Rab, Shasha Bai, Adrianna Westbrook, Carmel M. McNicholas, Jong In Hong, Candela Manfredi, C. Barillà, Shingo Suzuki, Brian R. Davis, Eric J. Sorscher
Topics & Concepts
IvacaftorCystic fibrosisMedicineCystic fibrosis transmembrane conductance regulatorClinical trialInternal medicineIntensive care medicineCystic Fibrosis Research AdvancesPediatric health and respiratory diseasesChemical and Physical Studies